58 results about "Double blind" patented technology

Embodiments disclosed herein are directed to systems and methods for enabling the matching of third party data with access providers' subscriber data in a privacy compliant manner, and then connecting an internet user to that third party data for use by marketers, content providers, or other interested parties in a manner that protects consumer privacy at all times. In one embodiment, an access provider such as an ISP sends its subscriber data to a double blind processor that generates an encrypted key for each subscriber. The key is then used to find matching consumer data, for example, consumer segments that represent previously collected or modeled consumer attitudinal, habit, or financial data. The key may be forwarded to a real time marketing bureau, which may use the matched data in subsequent real-time or substantially real-time operations to provide consumer or business data to advertisers, content providers, and other interested parties.

A Double Blinded Privacy-Safe Distributed Data Mining Protocol is disclosed, among an aggregator, a data consumer entity having privacy-sensitive information, and data source entities having privacy-sensitive information. The aggregator does not have access to the privacy-sensitive information at either the data consumer entity or the data source entities. The aggregator formulates a query without using privacy-sensitive information, and sends the query to the data consumer entity. The data consumer entity generates a list of specific instances that meet the conditions of the query and sends the list, encrypted, to the data source entities either directly or through the aggregator. The data source entities match the list against transactional data, de-identify the matched results, and send them to the aggregator. The aggregator combines results from data source entities and sends the combined result to the data consumer entity. This allows for privacy-safe data mining where both the data consumer entity and data source entities have privacy-sensitive information not available for the aggregator to see or use.

The present invention relates to soft contact lenses having an overall comfort preference of at least about 2 to 1 as compared to an Acuvue® contact lens and measured after one week of daily wear. The present invention further relates to a soft contact lens comprising an oxygen transmissibility greater than about 70 barrers/mm and physical properties suitable to provide wearer comfort over at least about 9 hours in at least about 80% of wearers, as measured in a randomized, double masked clinical study.

This invention relates to new safe natural drug, which is prevention of cancer and control of cancer cells. Specifically, this invention provides methods for producing of Berberine and Baicalin.Also, the present invention proved a new radioimmunoassay (RIA) method for precise determination of Berberine and Baicalin. The RIA is an efficient analytical method for large clinical programs including double blind analysis (DBA), and good clinical practice (GCP).

A system and associated protocols for communication between two entities across a computer network operate such that the identities of the two entities remain concealed from each other, while ensuring that no third party is able to trace the existence of a conversation between them. The two entities correspond to each other through pseudonyms. The protocols are designed with an object to distribute trust so that an identity is not revealed by the compromise of any one agent involved in the execution of the protocol. No one agent can establish a correlation between a pseudonym and a physical address.

A system for facilitating the bidding process to include a single computer portal is provided. The invention includes the use of a computer network system that can include modules that have the ability to analyze and process information unique to customers, contractors, and vendors associated with the bidding process on a multi-department level. The invention further provides for monitoring the progress of an accepted bid. A method for facilitating the bidding process is also provided.

A system and process performed by the system for identifying and tracking perpetrators of any of various types of crimes, including bullying, child pornography, sexual assault and rape, in reports which are anonymously reported to the system. The perpetrators can be of various categories, such as formally convicted, and/or formally charged and not convicted, and/or never been charged or not yet been caught, and therefore are without prior convictions or criminal records and are thereby not on law enforcement's radar. The system and process relies upon the reporting by a victim or a witness of information pertinent to an alleged criminal event. The identity of each reporting victim is never known to the system, unless the victim or witness goes to the police. The system uses a “double blind” method to protect the victim and certain details of the reported incident.

A system for protecting high-value cargo enclosed in a container, while maintaining the container indistinguishable from similar low value shipments, includes an onboard identity module (OBIM) cooperative with an internal locking mechanism (ILM), both of which are externally undetectable. The OBIM can secure the ILM and prevent the container from being opened until a properly encoded unlocking signal from a Security Management System (SMS) is wirelessly received by the OBIM. The unlocking signal can be a composite including a plurality of species of wireless signals such as different frequencies of AM and FM encoded RF and acoustic signals, transmitted simultaneously and/or at specified intervals. In embodiments the OBIM enables remote tracking of the container, and in some embodiments the tracking is double-blind, whereby a Master Number (MN) recorded in shipping documents is associated with a “Random Number” (RN) used for tracking, the association being known only to the SMS.

The invention discloses an electronic vision detecting system adopting double-blind design. The electronic vision detecting system adopting the double-blind design is characterized by comprising hardware and software, wherein the hardware mainly includes a blindfold plate, an infrared ray transmitter, an infrared ray receiver, a handheld controller, a processor, a bar code reader and a sighting mark displayer. The software installed in the processor mainly includes an identity recognition module, a sighting mark displaying module, a sighting mark progressive module, a dynamic distance measuring module, a vision conversion module and a storage module. The electronic vision detecting system displays different sighting marks through the sighting mark displayer, a tested person can freely select the distinguishing time and a checking distance within a certain range without participation of a doctor and meanwhile cannot know a specific vision vale represented by a vision line being detected in the detection process, and information difference of a testing person and the tested person is eliminated. The electronic vision detecting system adopts the double-blind design, automatically performs sighting mark selection/vision testing through the controller and accordingly reflects the real vision of the tested person accurately.

Eliminating actual and potential bias from a malpractice claim evaluation process utilizes a double blind evaluation method, which includes the steps of retention by an entity having a direct or indirect interest in the claim of a neutral third party to obtain an independent evaluation of the claim, acquisition by the third party of facts relating to the claim which are sufficient to permit an independent objective evaluation of the claim, retention by the third party of a qualified independent expert to perform the claim evaluation, redaction from the sufficient facts of all facts which would permit the expert to identify any party involved or having an interest in the claim, submission by the third party of the sufficient facts after redaction to the expert in order to permit the expert to make an independent objective evaluation of the claim, preparation by the expert of a written independent objective evaluation of the claim, submission of the written claim evaluation by the expert to the third party, redaction from the written claim evaluation of any information which would permit identification the expert, and submission of the evaluation after redaction to the entity retaining the third party.

A blind for a building opening, and having a head rail, attachable adjacent to the building opening; a first blind panel stored in the head rail, and adapted to be lowered as a loop defing two loop parts, over the building opening; a second blind panel stored in the head rail and adapted to be lowered over the building opening, and wherein the first panel is formed of light permeable material, whereby to admit at least some light into the interior of the building, and the second panel is formed of light impermeable material; transverse blind strips on the first panel, at spaced intervals there across; and, blind panel control mechanism in the head rail whereby the first blind panel loops can be adjusted so as to adjust the transverse blind strips between open and closed positions.

The invention uses serum specificity protein group fingerprint diagram to diagnose carcinoma of colon and rectal carcinoma in early stage, the invention produces the protein group template at first, selects the outer circle blood of confirmed sufferers, benign sufferer and normal people. Separates the serum in 4 degrees centigrade cold-storage, absorbs the serum centrifugally, packages, backup in subzero 80 degrees centigrade; when in detection, it is diluted according to a density; uses the metal chip of America saifuji corporation; sets in the fly mass spectrum device of America safifuji corporation, analyzes the protein group wave spectrum of the sample serum; compares and analyzes the serum protein group wave spectrum of the carcinoma of colon and rectal carcinoma sufferers, the benign sufferer and health people, acquires the special protein peak in the serum; forms the protein template by combining protein peak in serum, uses the template double-blind method to carry on clinic sifting experiment, confirms the positive predicting valve, negative predicting valve, sensitivity and specificity of the fingerprint diagram.

The invention provides a drug clinical testing method which is in particular suitable for the clinical trials of drugs for some fatal diseases. At present, the international general drug clinical testing employs the randomized controlled double-blind trial method which is characterized in that patients are divided into a trial group and a control group, and the patients in the trial group are given a tested drug for treatment while a placebo without any curative effect is given to the patients in the control group; if the drug is aimed at curing some fatal diseases which some conventional drugs cannot cure, such as terminal cancer, it is extremely inhuman for the patients in the control group because the patients in the control group are given the placebo without any curative effect only and are destined to die of the disease. The method provided by the invention is characterized in that the patients receiving the testing can get the same drug, and only the doses are different; if the drug passes the clinical testing successfully, some patients who are not cured because of the dose difference can recover by adjusting the doses according to clinical testing results; thus, the method conforms to the revolutionary humanitarian spirit of heating the wounded and rescue the dying.

The present invention provides an one-stop full-process archive information management method. The present invention comprises following steps: pasting box number bar codes on a voucher box, putting arranged archive files into the voucher box, filling out a container loading list, and sealing the box by using a privacy lock strip; putting the voucher box after being sealed into storage by archive administrators, and putting the voucher box on a ware location; and typing the archive information in a storage center management system and a client system. The one-stop full-process archive information management method is able to solve the problem that the archive management filing scope is small, enhance the archive business management, regulate the business operation, definite the work duty, improve the work efficiency and ensure the safe, efficient and stable operation of a system; the archive management is typed in the storage center management system and the client system, wherein the storage center management system is configured to determine the position of the voucher box, the client system is configured to record the content of the voucher box, and the two systems are operated by different persons so as to realize double-blind management.

The invention relates to the heat shock protein (HSP) 27 medical using. The invention uses the method of protein groupology to take animal mould experiment show that the HSP27 highly expressed. Immunohistochemistry testing result shows HSP27 locating in the liver cell cytoplasm; blood serum protein groupology found that HSP27 is owned by liver cancer; the Western Blot identification result shows HCC patient has strong HSP27(100%, 20/20); blood serum double blind testified normal blood serum do not display HSP27(0/10), HCC patient positive incidence is 100%(30/30). The result shows HSP27 protein could be used as the marking material protein to testing liver cancer. It could be used to make predict and diagnose medicine containing AFP negative HCC and the transformation.

The invention discloses a double-blind drug clinical test method and a double-blind drug clinical test system. The method comprises the following steps: generating a random allocation table, a drug number table and a secondary blind base comparison table; extracting a first random number from the random allocation table and allocating the first random number to a target object; obtaining a group corresponding to the first random number from the secondary blind base comparison table; and distributing the medicines corresponding to the groups to the target object from the medicine distribution table according to the sequence of the medicine numbers from small to large. The technical problem of medicine waste in an existing blind clinical test is solved.

The invention discloses a double-blind bidding and tendering system based on a block chain. An alliance chain building system is used and comprises a tendering module, a main module, a bidding moduleand an evaluation expert module, the main module generates a graph G for each specific tendering project, randomly generates a token for each bidding user and each evaluation expert user, performs hash calculation on the token and then stores the token; the bidding user or an evaluation expert user selects own private transformation ni or ni' to generate the same composition Gi or Gi' of the graphG, then a public transformation pi or pi' is selected, Gii or Gii' is generated on the basis of Gi or Gi', and then bidding information M or review information M' comprising pi or pi', Gii or Gii 'isconstructed. Therefore, the function of verifying whether the opposite side is an effective bidding user or an effective evaluation expert on the premise of hiding the real identity of the bidding user or the evaluation expert is realized. The invention further discloses a double-blind bidding and tendering method based on the block chain.

The invention discloses a traditional Chinese medicine diagnosis and treatment network platform based on artificial intelligence. The platform is characterized by comprising a login module, an information input module, a looking, listening, asking and pulse feeling four-diagnosis-method collection module, an electronic medical record module, an artificial intelligence module, a display module anda data storage and management module; the artificial intelligence module comprises one or a combination of two of an artificial intelligence learning sub-module and an artificial intelligence processing sub-module; the artificial intelligence learning sub-module further comprises a treatment plan efficacy evaluation component and a ranking component; the artificial intelligence processing sub-module also comprises a ranking component. The traditional Chinese medicine diagnosis and treatment network platform based on artificial intelligence can solve the problems that traditional Chinese medicine diagnosis and treatment methods are primitive, low in efficiency, unstable in state and scarce of quantitative evaluation, and medical data cannot be effectively developed; the research foundationof large-sample random double-blind control tests is consolidated to improve the level of traditional Chinese medicine as a whole.